Arrivent Biopharma, INC. (AVBP) SEC Filings — 2024
23 SEC filings for Arrivent Biopharma, INC. (AVBP) in 2024.
Filings
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Dec 4, 2024
- ArriVent BioPharma Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Nov 12, 2024
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Nov 12, 2024
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Nov 8, 2024
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Oct 24, 2024
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Oct 11, 2024
- ArriVent BioPharma Files 8-K Report — 8-K · Sep 9, 2024
- ArriVent BioPharma Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- ArriVent BioPharma Files 8-K/A Amendment — 8-K/A · Jul 9, 2024
- ArriVent BioPharma Enters Material Definitive Agreement — 8-K · Jun 5, 2024
- ArriVent BioPharma Appoints New CMOs — 8-K · May 16, 2024
- ArriVent BioPharma Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- ArriVent Biopharma Appoints New CMO, Elects Director — 8-K · Apr 22, 2024
- ArriVent Biopharma Files 8-K on Financials — 8-K · Mar 28, 2024
- ArriVent Biopharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Arrivent Biopharma, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- OrbiMed Discloses Active Stake in ArriVent Biopharma — SC 13D · Feb 5, 2024
- ArriVent Biopharma Files 8-K for Bylaw Amendments, Other Events — 8-K · Jan 30, 2024
- ArriVent Biopharma Files Amendment No. 2 to S-1 Registration Statement — S-1/A · Jan 23, 2024
- ArriVent Biopharma Files Amendment to S-1 Registration Statement — S-1/A · Jan 22, 2024
- ArriVent Biopharma Files S-1 Registration Statement — S-1 · Jan 5, 2024